CoLucid pockets $4M for PhIII migraine drug trial
Link: http://www.fiercebiotech.com/story/colucid-pockets-4m-phiii-migraine-drug-trial/2011-09-02
Media Coverage
Lasmiditan
Lasmiditan is a member of a novel chemical class called "ditans." Lasmiditan penetrates the central nervous system (CNS) and selectively targets 5-HT1F receptors expressed in the trigeminal nerve pathway.